National immunization schedule with dose route
India national immunization schedule 2025 dose route site age
https://ima-india.org/ima/pdfdata/Immunization_Schedule_CHAR…
| Beneficiary | Age | Vaccine | Dose | Route | Site |
|---|---|---|---|---|---|
| Infants | At Birth | BCG | 0.1 mL (neonates: 0.05 mL) | Intradermal (ID) | Left upper arm |
| bOPV-0 (zero dose) | 2 drops | Oral | Mouth | ||
| Hepatitis B (birth dose) | 0.5 mL | IM | Left anterolateral thigh | ||
| 6 Weeks | bOPV-1 | 2 drops | Oral | Mouth | |
| Pentavalent-1 (DPT+HepB+Hib) | 0.5 mL | IM | Anterolateral thigh | ||
| fIPV-1 (fractional IPV) | 0.1 mL | Intradermal (ID) | Right anterolateral thigh | ||
| RVV-1 (Rotavirus) | 5 drops | Oral | Mouth | ||
| PCV-1 | 0.5 mL | IM | Anterolateral thigh | ||
| 10 Weeks | bOPV-2 | 2 drops | Oral | Mouth | |
| Pentavalent-2 | 0.5 mL | IM | Anterolateral thigh | ||
| RVV-2 | 5 drops | Oral | Mouth | ||
| 14 Weeks | bOPV-3 | 2 drops | Oral | Mouth | |
| Pentavalent-3 | 0.5 mL | IM | Anterolateral thigh | ||
| fIPV-2 | 0.1 mL | ID | Right anterolateral thigh | ||
| RVV-3 | 5 drops | Oral | Mouth | ||
| PCV-2 | 0.5 mL | IM | Anterolateral thigh | ||
| 9-11 Months | MR-1 (Measles-Rubella) | 0.5 mL | SC | Right upper arm | |
| JE-1 (Japanese Encephalitis) | 0.5 mL | SC | Right upper arm | ||
| PCV Booster | 0.5 mL | IM | Anterolateral thigh | ||
| fIPV-3 | 0.1 mL | ID | Right anterolateral thigh | ||
| Vitamin A (1st dose) | 1 lakh IU (1 mL) | Oral | Mouth | ||
| Children | 16-23 Months | MR-2 | 0.5 mL | SC | Right upper arm |
| JE-2 | 0.5 mL | SC | Right upper arm | ||
| DPT Booster-1 | 0.5 mL | IM | Anterolateral thigh | ||
| bOPV Booster | 2 drops | Oral | Mouth | ||
| Vitamin A (2nd-9th dose, every 6 months up to 5 yrs) | 2 lakh IU (1 mL) | Oral | Mouth | ||
| 5-6 Years | DPT Booster-2 | 0.5 mL | IM | Upper arm | |
| 10 Years | Td | 0.5 mL | IM | Upper arm | |
| 16 Years | Td | 0.5 mL | IM | Upper arm | |
| Pregnant Women | At registration / 1st ANC | Td-1 | 0.5 mL | IM | Upper arm |
| 4 weeks after Td-1 | Td-2 | 0.5 mL | IM | Upper arm | |
| (If previously vaccinated within 3 yrs) | Td Booster | 0.5 mL | IM | Upper arm |
Key notes:
- Pentavalent = DPT + Hepatitis B + Hib (5-in-1 vaccine)
- fIPV = fractional dose Inactivated Polio Vaccine (1/5th of full dose) given intradermally
- JE vaccine is part of NIS in endemic states (UP, Bihar, West Bengal, Assam, Karnataka, etc.)
- Td replaced TT in India's NIS
| Age | Vaccine | Dose | Route | Site | Remarks |
|---|---|---|---|---|---|
| Birth | BCG | 0.05 mL | ID | Left upper arm | Within 24-72 h |
| OPV-0 | 2 drops | Oral | - | Before hospital discharge | |
| Hep B-0 | 0.5 mL | IM | Left thigh | Mandatory before discharge | |
| 6 Weeks | DTwP/DTaP-1 | 0.5 mL | IM | Anterolateral thigh | Use combination vaccines |
| Hib-1 | 0.5 mL | IM | Anterolateral thigh | ||
| IPV-1 | 0.5 mL | IM | Anterolateral thigh | ||
| Hep B-1 | 0.5 mL | IM | Anterolateral thigh | ||
| PCV10/13-1 | 0.5 mL | IM | Anterolateral thigh | ||
| Rota-1 | 0.5-2 mL | Oral | Squirt toward buccal mucosa | Do not give after 16 weeks | |
| 10 Weeks | DTwP/DTaP-2 | 0.5 mL | IM | Anterolateral thigh | |
| Hib-2 | 0.5 mL | IM | Anterolateral thigh | ||
| IPV-2 | 0.5 mL | IM | Anterolateral thigh | ||
| Hep B-2 | 0.5 mL | IM | Anterolateral thigh | ||
| PCV10/13-2 | 0.5 mL | IM | Anterolateral thigh | ||
| Rota-2 | 0.5-2 mL | Oral | Buccal mucosa | 2 doses for RV1 | |
| 14 Weeks | DTwP/DTaP-3 | 0.5 mL | IM | Anterolateral thigh | |
| Hib-3 | 0.5 mL | IM | Anterolateral thigh | ||
| IPV-3 | 0.5 mL | IM | Anterolateral thigh | ||
| Hep B-3 | 0.5 mL | IM | Anterolateral thigh | ||
| PCV10/13-3 | 0.5 mL | IM | Anterolateral thigh | ||
| Rota-3 | 0.5-2 mL | Oral | Buccal mucosa | RV5/RV116E (3 doses) | |
| 6 Months | Hep B | 0.5 mL | IM | - | If following 0, 1, 6 month schedule |
| OPV-1 | 2 drops | Oral | - | ||
| IIV-1 (Influenza) | 0.25 mL | IM | - | High-risk groups | |
| 7 Months | IIV-2 (Influenza) | 0.25 mL | IM | - | 2nd dose if first given at 6 months |
| 9 Months | OPV-2 | 2 drops | Oral | - | |
| MMR-1 / MR | 0.5 mL | SC | Right upper arm | After 270 completed days | |
| Meningococcal-1 | 0.5 mL | IM | - | High-risk groups | |
| 10 Months | Typhoid Conjugate (TCV)-1 | 0.5 mL | IM | - | ≥1 month gap after MMR |
| 12 Months | Hepatitis A-1 (killed or live) | 0.5 mL | IM (killed) or SC (live) | - | Single dose if live vaccine |
| JE-1 | 0.25 mL | IM | - | Endemic areas, <3 years | |
| Cholera | - | Oral | - | Hyperendemic/outbreak areas | |
| 13 Months | JE-2 | 0.25 mL | IM | - | Endemic areas |
| 15 Months | MMR-2 | 0.5 mL | SC | - | |
| Varicella-1 | 0.5 mL | SC | - | ||
| 15-18 Months | PCV Booster | 0.5 mL | IM | - | |
| 16-18 Months | DTwP/DTaP Booster-1 | 0.5 mL | IM | - | Combination vaccines preferred |
| IPV Booster | 0.5 mL | IM | - | ||
| Hib Booster | 0.5 mL | IM | - | ||
| 18 Months | Hepatitis A-2 (killed) | 0.5 mL | IM | - | 2nd dose only for killed vaccine |
| 2 Years | TCV-2 or Typhoid polysaccharide | 0.5 mL | IM | Upper arm | |
| Meningococcal-2 | 0.5 mL | IM | - | Single dose if first dose at/after 2 yrs | |
| 4-6 Years | DTwP/DTaP/Tdap (Booster-2) | 0.5 mL | IM | Upper arm | |
| OPV-3 (up to 5 years) | 2 drops | Oral | - | ||
| MMR-3 | 0.5 mL | SC | - | ||
| Varicella-2 | 0.5 mL | SC | - | Min 3 months after first dose | |
| 9 Years+ (girls) | HPV | 0.5 mL | IM | Upper arm | 2 doses (6 months apart) if started before 15th birthday; 3 doses if started at/after 15 yrs |
| 10 Years | Td / Tdap | 0.5 mL | IM | Upper arm | |
| 16 Years | Td | 0.5 mL | IM | Upper arm |
| Route | Vaccines |
|---|---|
| Intradermal (ID) | BCG (0.05-0.1 mL), fIPV (0.1 mL) |
| Oral | OPV, Rotavirus, Cholera, Vitamin A |
| Subcutaneous (SC) | MMR, Varicella, Hepatitis A (live), JE (some formulations) |
| Intramuscular (IM) | Hep B, DPT/DTwP/DTaP, Pentavalent, IPV (full dose), Hib, PCV, TCV, Typhoid, Meningococcal, HPV, Td, IIV (influenza) |